C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2006
11/28/2006	US7141569 Antiviral pyrazolopyridine compounds
11/28/2006	US7141567 such as (7R,8R,9R)-8-hydroxy-2-methyl-7-(2-methoxyethoxy)-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridine; for treatment of gastrointestinal disorders
11/28/2006	US7141565 Substituted quinobenzoxazine analogs
11/28/2006	US7141564 are active against a wide range of organisms including both Gram-negative and Gram-positive organisms
11/28/2006	CA2379640C Certain alkylene diamine-substituted heterocycles
11/28/2006	CA2305370C Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function
11/28/2006	CA2268305C Use of an h+, k+-atpase inhibitor in the treatment of nasal polyps
11/28/2006	CA2228044C Dibenzimidazole radioprotectors
11/28/2006	CA2137203C Protein kinase c inhibitors
11/28/2006	CA2113603C Tricyclic condensed heterocyclic compounds, their production and use
11/23/2006	WO2006125194A2 Piperazine derivatives and their uses as therapeutic agents
11/23/2006	WO2006125180A1 Piperazine derivatives and their uses as therapeutic agents
11/23/2006	WO2006125179A1 Tricyclic compounds and their uses as therapeutic agents
11/23/2006	WO2006124944A1 4, 6-diamino-[1,7] naphthyridine-3-carbonitrile inhibitors of tpl2 kinase and methods of making and using the same
11/23/2006	WO2006124863A2 Pyrrolopyridine derivatives as protein kinase inhibitors
11/23/2006	WO2006124731A2 Compounds and compositions as protein kinase inhibitors
11/23/2006	WO2006124462A2 Compounds and compositions as protein kinase inhibitors
11/23/2006	WO2006123726A1 Pharmaceutical composition
11/23/2006	WO2006123242A1 1, 2, 4 -triazole derivatives as vasopressin antagonists
11/23/2006	WO2006123061A2 Fluorene derivatives, composition containing said derivatives and the use thereof
11/23/2006	WO2006122931A1 Beta-carboline derivatives and theri use as ghsr modulators
11/23/2006	WO2006122806A2 1,3-dihydro-imidazo [4,5-c] quinolin-2-ones as lipid kinase inhibitors
11/23/2006	WO2006122403A1 Quinoline derivatives as ep4 antagonists
11/23/2006	WO2006089168A3 Methods for modulating ion channels
11/23/2006	WO2006087306A3 Diazabicyclic aryl derivatives and their use as cholinergic ligands at the nicotinic acetylcholine receptors
11/23/2006	WO2006084015A3 Raf inhibitor compounds and methods
11/23/2006	WO2006078865A3 Direct racemization of indole derivatives
11/23/2006	WO2005121139A8 Substituted tricyclic benzimidazoles
11/23/2006	WO2005077050A3 Hiv integrase inhibitors
11/23/2006	US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/23/2006	US20060264635 Process for the preparation of moxifloxacin hydrochloride
11/23/2006	US20060264630 Antidiabetic agents; modulate insulin drug resistance
11/23/2006	US20060264457 Such as 3-(Aminomethyl)-6-((S)-1-(cyclopropylsulfonyl)pyrrolidin-3-yl)-4-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one hydrochloride; for treatment of diabetes
11/23/2006	US20060264449 Compounds for modulation of kinesins as anticancer agents with administering
11/23/2006	US20060264441 N-[(1-azabicyclo[2.2.2]oct-2-yl)arylmethyl]-benzamide derivatives; psychological, behavioral, eating, sexual, sleep, nervous system, and/or neurodegenerative disorders; drug abuse, alcoholism, schizophrenia, psychoses, Parkinson*s disease, epilepsy; analgesics, antidepressants, anxiolytic agents
11/23/2006	US20060264440 Pyrazoles and methods of making and using the same
11/23/2006	US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006	US20060264429 Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
11/23/2006	US20060264428 Tri-, tetra-substituted-3-aminopyrrolidine derivative
11/23/2006	US20060264420 Tteating cell proliferation disease by modulation of kinesin and treatment of cancer
11/23/2006	US20060264419 Substituted pyrazoles
11/23/2006	DE60202452C5 Pyridazinonaldose reductase inhibitoren Reductase inhibitors Pyridazinonaldose
11/23/2006	CA2608718A1 1, 2, 4-triazole derivatives as vasopressin antagonists
11/23/2006	CA2608496A1 Imidazoquinolines as lipid kinase inhibitors
11/23/2006	CA2608378A1 New fluorene derivatives, compositions containing the same and use thereof
11/23/2006	CA2608362A1 4, 6-diamino-[1,7] naphthyridine-3-carbonitrile inhibitors of tpl2 kinase and methods of making and using the same
11/23/2006	CA2608333A1 Pyrrolopyridine derivatives as protein kinase inhibitors
11/23/2006	CA2608214A1 Quinoline derivatives as ep4 antagonists
11/23/2006	CA2607299A1 Compounds and compositions as protein kinase inhibitors
11/22/2006	EP1724295A1 Supramolecular complex of pyridylnaphthalenediimide with zinc porphyrin dendrimer having multiplicity of artificial photosynthetic reaction center
11/22/2006	EP1724271A1 Preventive and/or therapeutic agent for neutrophilic inflammation disease
11/22/2006	EP1724268A1 Compound having tgf-beta inhibitory activity and pharmaceutical composition containing same
11/22/2006	EP1724267A1 Pyrimidine derivative
11/22/2006	EP1724263A1 Basic amine compound and use thereof
11/22/2006	EP1724258A1 Heteroarylphenylurea derivative
11/22/2006	EP1723146A1 Fused pyrazole derivatives as tgf-beta signal transduction inhibitors for the treatment of fibrosis and neoplasms
11/22/2006	EP1723145A2 Substituted 5,12-diaza-benzoanthracene analogues
11/22/2006	EP1723137A1 Novel 4-benzimidazol-2-ylpyridazin-3-one derivatives
11/22/2006	EP1723123A1 Ion channel modulators
11/22/2006	EP1722995A1 Wheel drive
11/22/2006	EP1722826A2 Crf receptor antagonists, their preparations, their pharmaceutical composition and their uses
11/22/2006	EP1722796A2 Tetracyclic lactam derivatives and uses thereof
11/22/2006	EP1722795A1 Piperidinyl prostaglandin e analogs
11/22/2006	EP1722793A1 Bicyclic modulators of androgen receptor function
11/22/2006	EP1509520B1 Use of benzo(c)quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction
11/22/2006	EP1497291B1 Quinoline and aza-indole derivatives and their use as 5-ht6 ligands
11/22/2006	EP1483265B1 Purine derivatives as kinase inhibitors
11/22/2006	EP1360186B1 Carboline derivatives
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP1301487B1 Viral polymerase inhibitors
11/22/2006	EP1051176B1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/22/2006	CN1867568A Diazabicyclononene derivatives and their use as renin inhibitors
11/22/2006	CN1867555A Rearranged pentanols, a process for their production and their use as anti-inflammatory agents
11/22/2006	CN1867549A Cyclopropyl derivatives as NK3 receptor antagonists
11/22/2006	CN1867334A Quinolinone derivatives as inhibitors of c-fms kinase
11/22/2006	CN1867331A Thalidomide analogs as TNF-alpha modulators
11/22/2006	CN1285656C Fluorescent pigment composition
11/22/2006	CN1285594C Oxytocin agonists
11/21/2006	US7138533 acetylcholinesterase inhibitory action and an alpha 1 antagonistic action
11/21/2006	US7138411 Substituted benzopyran derivatives for the treatment of inflammation
11/21/2006	US7138409 Heterocyclic compounds
11/21/2006	US7138408 Beta-carboline hydroxamic acid derivatives, used to treat AIDS and AIDS-related complex
11/21/2006	US7138399 2-[2-(4-alkoxypyridin-2-yl)alkyl])-3H-imidazo[4,5-b]pyridine derivatives and 8-[2-(4-alkoxypyridin-2-yl)alkyl])-9H-purine derivatives; used to treat an acute inflammatory disease in which the activity of inducible NO-synthase is involved
11/21/2006	US7138397 Nitrogenous 5-membered ring compounds
11/21/2006	US7138395 Interleukin-1β converting enzyme inhibitors
11/21/2006	CA2272285C Amide derivatives and medicinal compositions thereof
11/21/2006	CA2220080C Method for making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form
11/16/2006	WO2006122137A1 1, 6 -dihydro- 1,3, 5, 6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same as inhibitors of ikk enzyme activity
11/16/2006	WO2006121655A1 Process for making fluorinated 4-azasteroid derivatives and intermediate thereof
11/16/2006	WO2006121518A2 Electrical devices, anti-scarring agents, and therapeutic compositions
11/16/2006	WO2006120573A2 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors
11/16/2006	WO2006120478A2 Quinoline derivatives as neurokinin receptor antagonists
11/16/2006	WO2006120133A2 Process for coloring keratin fibers comprising metal complexes
11/16/2006	WO2006119694A1 Quinolinone carboxylic acid derivatives, the preparation and the use thereof
11/16/2006	WO2006086705B1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/16/2006	WO2002094236A9 Delivery of antipsychotics through an inhalation route
11/16/2006	US20060258859 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
11/16/2006	US20060258700 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
11/16/2006	US20060258689 Fused heterocyclic compounds, and compositions and uses thereof
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors

1 ... 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 ... 646